BRÈVE

sur Carl Zeiss Meditec AG (ETR:AFX)

Leadership Change at Carl Zeiss Meditec AG

Graphique de l'évolution du cours de l'action Carl Zeiss Meditec AG (EBR:AFX).

Carl Zeiss Meditec AG announces a significant leadership shift. Current President and CEO, Dr. Markus Weber, will step down on May 31, 2025. His position will be assumed by Maximilian Foerst, who presently leads ZEISS Greater China. This transition, requested by Dr. Weber, is amicable, ensuring continued management stability at the company.

Maximilian Foerst has an extensive background with Carl Zeiss AG, beginning in 1995. He has been instrumental in acquiring market leadership in China's refractive laser and intraocular lens sectors. With Greater China accounting for 26% of Carl Zeiss Meditec's revenue in 2023/24, his contributions have been pivotal.

Foerst will also join Carl Zeiss AG's Executive Board, taking over Dr. Weber's duties. The Supervisory Board expects smooth continuity, with CFO Justus Felix Wehmer remaining in his role. Strategic Business Units in Ophthalmology and Microsurgery are unaffected.

R. E.

Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Carl Zeiss Meditec AG